Targeting epidermal growth factor receptor in head and neck cancer.
about
Survival of cancer cells is maintained by EGFR independent of its kinase activitySTAT3 as a therapeutic target in head and neck cancerA dynamic oral cancer field: unraveling the underlying biology and its clinical implication.The role of human papillomavirus 16 E6 in anchorage-independent and invasive growth of mouse tonsil epithelium.Combination of phosphorylated and truncated EGFR correlates with higher tumor and nodal stage in head and neck cancerProteoglycans in health and disease: new concepts for heparanase function in tumor progression and metastasis.Cetuximab and irinotecan interact synergistically to inhibit the growth of orthotopic anaplastic thyroid carcinoma xenografts in nude mice.Overexpression of TACE and TIMP3 mRNA in head and neck cancer: association with tumour development and progression.Progress and perspectives in chemoprevention of head and neck cancer.Pre-clinical characterization of Dacomitinib (PF-00299804), an irreversible pan-ErbB inhibitor, combined with ionizing radiation for head and neck squamous cell carcinoma.Heparanase localization and expression by head and neck cancer: correlation with tumor progression and patient survivalSignal transducers and activators of transcription: insights into the molecular basis of oral cancer.Chromosomal aberrations in squamous cell carcinomas of the upper aerodigestive tract: biologic insights and clinical opportunities.Herpes simplex virus 1 (HSV-1) for cancer treatment.Utility of 3'-[(18)F]fluoro-3'-deoxythymidine as a PET tracer to monitor response to gene therapy in a xenograft model of head and neck carcinoma.Ron tyrosine kinase receptor synergises with EGFR to confer adverse features in head and neck squamous cell carcinoma.Heparanase augments epidermal growth factor receptor phosphorylation: correlation with head and neck tumor progression.Immunotherapy in head and neck cancer: current practice and future possibilities.ErbB receptors in the biology and pathology of the aerodigestive tractMolecular biology of head and neck cancer: risks and pathways.Functional genomics and proteomics approaches to study the ERBB network in cancer.Targeting the EGF receptor ectodomain in the context of cancer.EGF induces epithelial-mesenchymal transition and cancer stem-like cell properties in human oral cancer cells via promoting Warburg effect.Rational use of cetuximab in the treatment of advanced non-small cell lung cancer.Role of hyaluronan-mediated CD44 signaling in head and neck squamous cell carcinoma progression and chemoresistance.Recombinant IgE antibody engineering to target EGFR.Suppression of EGFR-STAT3 signaling inhibits tumorigenesis in a lung cancer cell line.Impaired PTPN13 phosphatase activity in spontaneous or HPV-induced squamous cell carcinomas potentiates oncogene signaling through the MAP kinase pathwayA novel mechanism for anti-EGFR antibody action involves chemokine-mediated leukocyte infiltration.Epidermal growth factor receptor-targeted therapy.Small interfering RNA targeting epidermal growth factor receptor enhances chemosensitivity to cisplatin, 5-fluorouracil and docetaxel in head and neck squamous cell carcinoma.Expression of KIT, EGFR, HER-2 and tyrosine phosphorylation in undifferentiated thyroid carcinoma: implication for a new therapeutic approach.Human Papillomavirus Regulates HER3 Expression in Head and Neck Cancer: Implications for Targeted HER3 Therapy in HPV+ Patients.Prolonged biologically active transgene expression driven by HSV LAP2 in brain in vivo.Cannabis smoke can be a major risk factor for early-age laryngeal cancer--a molecular signaling-based approach.It's all in for the HER family in tumorigenesis.Suppression of c-MET overcomes erlotinib resistance in tongue cancer cells
P2860
Q24309274-B6833BF3-072A-4557-AA76-387078A1123BQ28299368-4B766080-9C24-4BB8-B53B-24C3784A3FDDQ33911094-6AFFF993-7F75-4BDC-B55C-B9D7D41F2E56Q34049382-6ED3D7AA-94AD-4830-957B-720551966749Q34318204-516B52EA-44B9-4D10-8E04-D845DDD1F09FQ34398151-5C875B7D-7328-4049-A52A-BA1D877FEEAAQ34455658-0BC36C86-982E-4BAA-BC8B-EA7D8FC1650DQ34577446-7FCC3841-7667-4243-BCBA-36C26AEC62C8Q35160205-850B0523-9569-4B4C-A12F-5AE32F7FC490Q35172674-03AC3A51-109C-416F-ABC4-10EF32E3F95CQ35613227-19DD04BE-1B93-4D11-AF7A-FC0A17EE2D50Q35911353-7E15F6B0-C62B-411F-8D37-26F0BAC1CDE3Q36223578-3E05BB72-B224-4467-B775-8895226A3DE5Q36444443-567BBCF9-76AE-4082-93C6-F1D59AFB1D01Q36533822-EFFCA9BF-5AA5-41A8-88B6-9FFBC216EF96Q37040636-935F204F-0CBF-48CD-86F3-9F9CDA2202F3Q37194268-699D101A-DF16-4749-9C8A-BC6BD4ADAFBAQ37257768-0904CAC6-7434-4B0E-9F3C-52CCE60282F1Q37263452-DBEA8C5A-9FEA-469A-893C-3E0B00EA1C81Q37325829-BA1F8463-B7E4-4A4C-98BD-17CA4D43220DQ37419924-FD092D74-29E8-4863-8286-435571D51521Q37600910-8428C45B-9BE3-4145-A4F0-78449F284E6BQ37706017-BBC3119F-251B-44A6-BB7D-19722305C4BCQ37771250-75796D37-0FEF-4520-8F3A-8A9F96D57F90Q37847694-A9C17409-020D-43BB-B006-42588D8DF582Q38016758-C8426BB1-9AD6-4B4A-9B6D-6A3A557F7155Q38955418-0D454BD5-EA87-4CB7-A1FC-569BAD08EE84Q39802740-B4F797B1-FCA8-4923-8556-73621DCFF243Q39885205-3D38293A-9B20-4639-96C9-095FBFE4DB15Q40038133-5CD057DA-5DDC-448A-B82E-FE2E1B839E6DQ40230093-1E59C5C8-15CB-4359-9DEB-2F18F354F383Q40351569-319E688C-4ABC-4909-BF41-CD13368D6226Q40406103-BFE7DC93-6831-485A-A688-5033B10C3FC7Q40539291-FBBBF45E-D84B-4FCF-B860-43A88B052B97Q41304626-222DB71A-568D-40DB-9DC7-F1FBD553E743Q43215432-2D440AF6-429F-4999-9161-7E83FD91EC07Q58762813-A62855C4-7D78-418B-8A24-C885C0566F78
P2860
Targeting epidermal growth factor receptor in head and neck cancer.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Targeting epidermal growth factor receptor in head and neck cancer.
@ast
Targeting epidermal growth factor receptor in head and neck cancer.
@en
type
label
Targeting epidermal growth factor receptor in head and neck cancer.
@ast
Targeting epidermal growth factor receptor in head and neck cancer.
@en
prefLabel
Targeting epidermal growth factor receptor in head and neck cancer.
@ast
Targeting epidermal growth factor receptor in head and neck cancer.
@en
P356
P1433
P1476
Targeting epidermal growth factor receptor in head and neck cancer.
@en
P2093
Allison Carter Ford
Jennifer Rubin Grandis
P356
10.1002/HED.10224
P577
2003-01-01T00:00:00Z